ABSTRACT
Objective:To observe the clinical efficacy and safety of modified Xiao Chengqitang combined with acupoint catgut implantation in treating diet-induced obesity （DIO） syndrome of stomach heat dampness obstruction. Method:One hundred and seventy-two patients were randomly divided into control group（84 cases） and observation group（88 cases）. Both groups of patients received diet and exercise lifestyle adjustments， and acupoint catgut implantation was performed， 10 days for 1 time， 5 days intervals and then catgut implantation again， for a total of 6 times. Patients in observation group took modified Xiao Chengqitang granular powder， 10 g/time， with lukewarm boiled water in morning and evening. Patients in control group took modified Xiao Chengqitang granular powder simulant， 10 g/time， with lukewarm boiled water， 2 times/day. The treatment courses continued 4 months in two groups. Then the body mass index （BMI）， fat percentage （F%）， obesity， waist to hip ratio （WHR） were measured before and after treatment. Color Doppler ultrasonography was used to measure abdominal fat thickness， prehepatic fat thickness （AHF）， perirenal fat thickness （PRF）， and visceral fat index （UVI）. Fasting blood glucose （FBG）， triglyceride （TG）， total cholesterol （TC）， high-density lipoprotein-cholesterol （HDL-C）， low-density lipoprotein-cholesterol （LDL-C）， fasting insulin （FINS）， leptin （LP）， and adiponectin （APN） were detected before and after treatment， and the homeostasis model assessment of insulin resistance （HOMA-IR） index was calculated. In addition， safety evaluation was also conducted. Result:The BMI， F%， obesity degree and WHR in observation group were all lower than those in control group （<italic>P</italic><0.05 or <italic>P</italic><0.01）. Subcutaneous fat thickness， AHF， PRF and UVI in observation group were lower than those in control group （<italic>P</italic><0.01）. The TG， TC， LDL-C and FINS levels in observation group were lower than those in control group （<italic>P</italic><0.01）. The LP and HOMA-IR were also lower than those in control group （<italic>P</italic><0.01）， while the APN was higher than that in control group （<italic>P</italic><0.01）. The total effective rate in clinical application was （71/80） 88.75% in the observation group， higher than （57/75） 76.00% in the control group （<italic>χ</italic><sup>2</sup>=4.374，<italic> P</italic><0.05）. Conclusion:Modified Xiao Chengqitang combined with acupoint catgut implantation in treating DIO syndrome of stomach heat dampness obstruction can adjust LP， APN and other factors， improve energy metabolism such as sugar and fat， and effectively control obesity with high safety， so it is worthy of clinical use.
ABSTRACT
【Objective】To explore the effect of acupoint catgut implantation(ACI) on hypothalamic monoamine neurotransmitters in rats treated with clozapine.【Methods】Thirty-six SD rats were randomized into ACI group,clozapine group and blank control group.Except the blank control group,the rats in other two groups received clozapine.The dosage of clozapine for the rats was 5 mg?kg-1?d-1 at the first time,increased to 30 mg?kg-1?d-1,and then reduced to 22 mg?kg-1?d-1 which maintained till the end of the experiment.After 60-day treatment with clozapine,ACI group was treated with ACI alternatively on Baihui(GV20),bilateral Xinshu(BL15) and bilateral Quchi(LI11),or on Dazhui(GV14),bilateral Pishu(BL20),bilateral Zusanli(ST36),one time every 5 days,12 times in total.The changes of body weight before and after treatment,and the hypothalamic monoamine neurotransmitters contents of dopamine(DA) and 5-hydroxytryptamine(5-HT) were observed in the three groups.【Results】In the clozapine group,the rats body weight markedly increased,and the contents of DA and 5-HT decreased(P